New advance to the Theranexus and BBDF Batten-1 program for juvenile
Batten disease (CLN3)
Read the press release from Beyond Batten and Theranexus regarding Phase I/II trial data at the link below.
They are hosting a Quarterly Family Research call on Thursday, January 19 at 9.30pm UK time to provide an update on Batten-1 (previously BBDF 101) and other scientific advances in CLN3 disease.
You must register in advance to participate in the call. You can sign up at the link here…. https://sam-firm.zoom.us/meeting/register/tZ0sf-mtqDoiG9DsthDUwnfwXHrYvJNR0UPO
If you are not able to participate, we will make the recording available. If you have specific questions, please send them in advance to email@example.com so we can be sure to address them in the presentation.
We hope you can join them for this meeting.